RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 227,892 Value ($000) $1,520 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 144,013 Value ($000) $1,110 Avg Close $9.81 Range $7.04 - $13.29